SARS-COV-2 and COVID-19 - A Randomized controlled trail (unblinded)

INTERVENTION: Intervention1: Nilavembu kudineer Kabasura kudineer Thippili rasayanam Aadathodai manapagu Swasakudori maathirai Thoothuvalai legiyam Amukara chooranam Seenilnthil chooranam Pavala parpam Silasathu parpam Sivanar amirtham Muthu parpam Gargle‐ with Turmeric,Thripala,Alum,Glycyrrhiza glabra,Salt: Nilavembu kudineer‐60ml bd oral administration for 14 days kabasura kudineer‐60ml bd oral administration for 14 days thippili rasayanam‐ 5gm bd oral administration for 14 days aadathodai manapagu‐ 5ml BD hotwater oral administration for 14 days swasakudori maathirai‐2 bd hot water oral administration for 14 days thoothuvalai legiyam‐ 5gm bd with milk oral administration for 14 days amukara chooranam‐2gm bd oral administration for 14 days seenthil chooranam ‐2gm bd oral administration for 14 days pavala parpam‐100mg bd oral administration for 14 days silasathu parpam‐ 100mg oral administration bd for 14 days sivanar amirtham‐60g bd oral administration for 14 days muthu parpam‐100mg bd oral administration for 14 days Gargle‐ with Turmeric,Thripala,Alum,Glycyrrhiza glabra,Salt Control Intervention1: tab azithromycin Tab Hydroxychloroquinine tab paracitamol tab vitamin c tab zinc tab multivitamin inj enoxaparin inj methylperenidasolone kabasura kudineer: tab azithromycin 500mg bd oral administration Tab Hydroxychloroquinine 200mg oral administration tab paracitamol650mg bd oral administration inj methylperenidasolone intravenous inj enoxaparin intravenous tab vitamin c oral administration tab zinc oral administration tab multivitamin oral administration kabasura kudineer 60ml oral administration CONDITION: Health Condition 1: B972‐ Coronavirus as the cause of diseases classified elsewhere PRIMARY OUTCOME: Outcomes is mainly assessed by reduction in Clinical symptoms and Rt‐PCR test NegativeTimepoint: 3 Months SECONDARY OUTCOME: Outcomes is mainly assessed by reduction in Clinical symptoms and Rt‐PCR test Negative ; The outcome is assessed by patients recovery progress with faster reductions in clinical symptoms and Rt‐PCR test negative,also to avoid the mortality rate by administering Allopathy and Siddha medicines for the easy recovery and saftety measures in the treatment for SARS‐CoV‐2 and COVID‐19.Timepoint: 3 Months INCLUSION CRITERIA: Rt‐PCR positive patients, Asymptomatic patients, Fever, Dry cough, Sore throat, Difficulty in breathing